Pharma Journalist - Page 753 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Inception Neuroscience Program Acquired by Roche

Proteostasis’ triple combination program secures FDA fast track designation for cystic fibrosis

Alkermes Receives Refusal to File Letter From FDA for ALKS 5461

FDA accepts BLA for moxetumomab pasudotox in hairy cell leukaemia

Compugen Announces License Agreement With MedImmune for antibody products

Q-State Biosciences and Vertex Pharma Enter into Multi-Year Drug Discovery Collaboration

Hear From Boehringer-Ingelheim and Janssen at SMi’s 6th annual conference Pharmaceutical Freeze Drying Technology

Puma and Pint Pharma to Commercialize NERLYNX (neratinib) in Latin America

SpinalCyte Announces MRI Evidence of Disc Regeneration Following Phase 1/Phase 2 Clinical Trial of CybroCell Dermal Fibroblasts

PharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation